

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in the epidemiology and... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/9-338/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/9-338" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in the epidemiology and prevention of Streptococcus pneumoniae infections" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in the epidemiology and prevention of &lt;i&gt;Streptococcus pneumoniae&lt;/i&gt; infections.">
            <meta name="og:description" content="Read the latest article version by Charles Feldman, Ronald Anderson, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="24646">
            <meta name="article-id" content="22341">
            <meta name="dc.title" content="Recent advances in the epidemiology and prevention of &lt;i&gt;Streptococcus pneumoniae&lt;/i&gt; infections">
            <meta name="dc.description" content="The introduction of pneumococcal conjugate vaccines (PCVs) 7 and 13 into national childhood immunization programs in the US in 2000 and 2010, respectively, proved to be remarkably successful in reducing infant mortality due to invasive pneumococcal disease (IPD), resulting in widespread uptake of these vaccines. Secondary herd protection of non-vaccinated adults against IPD has proven to be an additional public health benefit of childhood immunization with PCVs, particularly in the case of the vulnerable elderly who are at increased risk due to immunosenescence and underlying comorbidity. Despite these advances in pneumococcal immunization, the global burden of pneumococcal disease, albeit of unequal geographic distribution, remains high. Reasons for this include restricted access of children living in many developing countries to PCVs, the emergence of infection due to non-vaccine serotypes of the pneumococcus, and non-encapsulated strains of the pathogen. Emerging concerns affecting the elderly include the realization that herd protection conferred by the current generation of PCVs (PCV7, PCV10, and PCV13) has reached a ceiling in many countries at a time of global population aging, compounded by uncertainty surrounding those immunization strategies that induce optimum immunogenicity and protection against IPD in the elderly. All of the aforementioned issues, together with a consideration of pipeline and pending strategies to improve access to, and serotype coverage of, PCVs, are the focus areas of this review.">
            <meta name="dc.subject" content="herd protection, invasive pneumococcal disease, pneumococcus, pneumococcal conjugate vaccine, prime-boost immunization, pneumococcal polysaccharide vaccine 23, serotype replacement, Streptococcus pneumoniae">
            <meta name="dc.creator" content="Feldman, Charles">
            <meta name="dc.creator" content="Anderson, Ronald">
            <meta name="dc.date" content="2020/05/07">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.22341.1">
            <meta name="dc.source" content="F1000Research 2020 9:338">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="herd protection">
            <meta name="prism.keyword" content="invasive pneumococcal disease">
            <meta name="prism.keyword" content="pneumococcus">
            <meta name="prism.keyword" content="pneumococcal conjugate vaccine">
            <meta name="prism.keyword" content="prime-boost immunization">
            <meta name="prism.keyword" content="pneumococcal polysaccharide vaccine 23">
            <meta name="prism.keyword" content="serotype replacement">
            <meta name="prism.keyword" content="Streptococcus pneumoniae">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2020/05/07">
            <meta name="prism.volume" content="9">
            <meta name="prism.number" content="338">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.22341.1">
            <meta name="prism.url" content="https://f1000research.com/articles/9-338">
            <meta name="citation_title" content="Recent advances in the epidemiology and prevention of &lt;i&gt;Streptococcus pneumoniae&lt;/i&gt; infections">
            <meta name="citation_abstract" content="The introduction of pneumococcal conjugate vaccines (PCVs) 7 and 13 into national childhood immunization programs in the US in 2000 and 2010, respectively, proved to be remarkably successful in reducing infant mortality due to invasive pneumococcal disease (IPD), resulting in widespread uptake of these vaccines. Secondary herd protection of non-vaccinated adults against IPD has proven to be an additional public health benefit of childhood immunization with PCVs, particularly in the case of the vulnerable elderly who are at increased risk due to immunosenescence and underlying comorbidity. Despite these advances in pneumococcal immunization, the global burden of pneumococcal disease, albeit of unequal geographic distribution, remains high. Reasons for this include restricted access of children living in many developing countries to PCVs, the emergence of infection due to non-vaccine serotypes of the pneumococcus, and non-encapsulated strains of the pathogen. Emerging concerns affecting the elderly include the realization that herd protection conferred by the current generation of PCVs (PCV7, PCV10, and PCV13) has reached a ceiling in many countries at a time of global population aging, compounded by uncertainty surrounding those immunization strategies that induce optimum immunogenicity and protection against IPD in the elderly. All of the aforementioned issues, together with a consideration of pipeline and pending strategies to improve access to, and serotype coverage of, PCVs, are the focus areas of this review.">
            <meta name="citation_description" content="The introduction of pneumococcal conjugate vaccines (PCVs) 7 and 13 into national childhood immunization programs in the US in 2000 and 2010, respectively, proved to be remarkably successful in reducing infant mortality due to invasive pneumococcal disease (IPD), resulting in widespread uptake of these vaccines. Secondary herd protection of non-vaccinated adults against IPD has proven to be an additional public health benefit of childhood immunization with PCVs, particularly in the case of the vulnerable elderly who are at increased risk due to immunosenescence and underlying comorbidity. Despite these advances in pneumococcal immunization, the global burden of pneumococcal disease, albeit of unequal geographic distribution, remains high. Reasons for this include restricted access of children living in many developing countries to PCVs, the emergence of infection due to non-vaccine serotypes of the pneumococcus, and non-encapsulated strains of the pathogen. Emerging concerns affecting the elderly include the realization that herd protection conferred by the current generation of PCVs (PCV7, PCV10, and PCV13) has reached a ceiling in many countries at a time of global population aging, compounded by uncertainty surrounding those immunization strategies that induce optimum immunogenicity and protection against IPD in the elderly. All of the aforementioned issues, together with a consideration of pipeline and pending strategies to improve access to, and serotype coverage of, PCVs, are the focus areas of this review.">
            <meta name="citation_keywords" content="herd protection, invasive pneumococcal disease, pneumococcus, pneumococcal conjugate vaccine, prime-boost immunization, pneumococcal polysaccharide vaccine 23, serotype replacement, Streptococcus pneumoniae">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Charles Feldman">
            <meta name="citation_author_institution" content="Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, Johannesburg, 2193, South Africa">
            <meta name="citation_author" content="Ronald Anderson">
            <meta name="citation_author_institution" content="Institute of Cellular and Molecular Medicine, Department of Immunology, Faculty of Health Sciences, University of Pretoria, 5 Bophelo Road, Gezina, 0186, South Africa">
            <meta name="citation_publication_date" content="2020/05/07">
            <meta name="citation_volume" content="9">
            <meta name="citation_publication_number" content="338">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.22341.1">
            <meta name="citation_firstpage" content="338">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/9-338/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/9-338.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=24646 /> <input type=hidden id=articleId name=articleId value=22341 /> <input type=hidden id=xmlUrl value="/articles/9-338/v1/xml"/> <input type=hidden id=xmlFileName value="-9-338-v1.xml"> <input type=hidden id=article_uuid value=60252632-e04b-4a09-a4b7-022abdcc1362 /> <input type=hidden id=referer value=""/> <input type="hidden" id="meta-article-title" value="Recent advances in the epidemiology and prevention of <i>Streptococcus pneumoniae</i> infections" /> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.22341.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.22341.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/9-338"
  },
  "headline": "Recent advances in the epidemiology and prevention of Streptococcus pneumoniae infections",
  "datePublished": "2020-05-07T11:21:27",
  "dateModified": "2020-05-07T11:21:27",
  "author": [
    {
      "@type": "Person",
      "name": "Charles Feldman"
    },    {
      "@type": "Person",
      "name": "Ronald Anderson"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "The introduction of pneumococcal conjugate vaccines (PCVs) 7 and 13 into national childhood immunization programs in the US in 2000 and 2010, respectively, proved to be remarkably successful in reducing infant mortality due to invasive pneumococcal disease (IPD), resulting in widespread uptake of these vaccines. Secondary herd protection of non-vaccinated adults against IPD has proven to be an additional public health benefit of childhood immunization with PCVs, particularly in the case of the vulnerable elderly who are at increased risk due to immunosenescence and underlying comorbidity. Despite these advances in pneumococcal immunization, the global burden of pneumococcal disease, albeit of unequal geographic distribution, remains high. Reasons for this include restricted access of children living in many developing countries to PCVs, the emergence of infection due to non-vaccine serotypes of the pneumococcus, and non-encapsulated strains of the pathogen. Emerging concerns affecting the elderly include the realization that herd protection conferred by the current generation of PCVs (PCV7, PCV10, and PCV13) has reached a ceiling in many countries at a time of global population aging, compounded by uncertainty surrounding those immunization strategies that induce optimum immunogenicity and protection against IPD in the elderly. All of the aforementioned issues, together with a consideration of pipeline and pending strategies to improve access to, and serotype coverage of, PCVs, are the focus areas of this review."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/9-338/v1",
            "name": "Recent advances in the epidemiology and prevention of Streptococcus..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in the epidemiology and prevention of Streptococcus... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=24646 data-id=22341 data-downloads="" data-views="" data-scholar="10.12688/f1000research.22341.1" data-recommended="" data-doi="10.12688/f1000research.22341.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/9-338/v1/pdf?article_uuid=60252632-e04b-4a09-a4b7-022abdcc1362" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-22341-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-22341-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-22341-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Feldman C and Anderson R. Recent advances in the epidemiology and prevention of <i>Streptococcus pneumoniae</i> infections [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):338 (<a class=new-orange href="https://doi.org/10.12688/f1000research.22341.1" target=_blank>https://doi.org/10.12688/f1000research.22341.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-22341-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=22341 id=track-article-signin-22341 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/22341?target=/articles/9-338/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=24646 /> <input name=articleId type=hidden value=22341 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in the epidemiology and prevention of <i>Streptococcus pneumoniae</i> infections</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:charles.feldman@wits.ac.za" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Charles Feldman</span></a><a href="https://orcid.org/0000-0002-6881-8314" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6881-8314</div><sup>1</sup><sup>*</sup>,&nbsp;</span><span class="">Ronald Anderson<sup>2</sup><sup>*</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:charles.feldman@wits.ac.za" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Charles Feldman</span></a><a href="http://orcid.org/0000-0002-6881-8314" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6881-8314</div><sup>1</sup><sup>*</sup>,&nbsp;</span><span class="">Ronald Anderson<sup>2</sup><sup>*</sup></span></div> </div> <div class="authors extra-info"> <sup>*</sup> Equal contributors </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 07 May 2020 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.22341.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, Johannesburg, 2193, South Africa<br/> <sup>2</sup> Institute of Cellular and Molecular Medicine, Department of Immunology, Faculty of Health Sciences, University of Pretoria, 5 Bophelo Road, Gezina, 0186, South Africa<br/> <p> <div class=margin-bottom> Charles Feldman <br/> <span>Roles: </span> Conceptualization, Data Curation, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Ronald Anderson <br/> <span>Roles: </span> Conceptualization, Data Curation, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=67270-63157></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=67269-63156></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> The introduction of pneumococcal conjugate vaccines (PCVs) 7 and 13 into national childhood immunization programs in the US in 2000 and 2010, respectively, proved to be remarkably successful in reducing infant mortality due to invasive pneumococcal disease (IPD), resulting in widespread uptake of these vaccines. Secondary herd protection of non-vaccinated adults against IPD has proven to be an additional public health benefit of childhood immunization with PCVs, particularly in the case of the vulnerable elderly who are at increased risk due to immunosenescence and underlying comorbidity. Despite these advances in pneumococcal immunization, the global burden of pneumococcal disease, albeit of unequal geographic distribution, remains high. Reasons for this include restricted access of children living in many developing countries to PCVs, the emergence of infection due to non-vaccine serotypes of the pneumococcus, and non-encapsulated strains of the pathogen. Emerging concerns affecting the elderly include the realization that herd protection conferred by the current generation of PCVs (PCV7, PCV10, and PCV13) has reached a ceiling in many countries at a time of global population aging, compounded by uncertainty surrounding those immunization strategies that induce optimum immunogenicity and protection against IPD in the elderly. All of the aforementioned issues, together with a consideration of pipeline and pending strategies to improve access to, and serotype coverage of, PCVs, are the focus areas of this review. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> herd protection, invasive pneumococcal disease, pneumococcus, pneumococcal conjugate vaccine, prime-boost immunization, pneumococcal polysaccharide vaccine 23, serotype replacement, Streptococcus pneumoniae </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Charles Feldman (<a href="mailto:charles.feldman@wits.ac.za">charles.feldman@wits.ac.za</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Charles Feldman </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> CF has acted on the advisory board and speakers bureau for Pfizer. RA declares that he has no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2020 Feldman C and Anderson R. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Feldman C and Anderson R. Recent advances in the epidemiology and prevention of <i>Streptococcus pneumoniae</i> infections [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):338 (<a href="https://doi.org/10.12688/f1000research.22341.1" target=_blank>https://doi.org/10.12688/f1000research.22341.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 07 May 2020, <b>9</b>(F1000 Faculty Rev):338 (<a href="https://doi.org/10.12688/f1000research.22341.1" target=_blank>https://doi.org/10.12688/f1000research.22341.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 07 May 2020, <b>9</b>(F1000 Faculty Rev):338 (<a href="https://doi.org/10.12688/f1000research.22341.1" target=_blank>https://doi.org/10.12688/f1000research.22341.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d4550e161>Introduction</h2><p class="" id=d4550e164>Worldwide, lower respiratory tract infections (LRTIs) are a major cause of morbidity and mortality. A systematic analysis of the Global Burden of Disease Study 2016 documented that LRTIs, encompassing pneumonia and bronchiolitis, accounted for 2,377,697 deaths (95% uncertainty interval [UI] 2,145,584–2,512,809) overall in 2016, encompassing 652,572 deaths (586,475–720,612) in children younger than 5, and, more strikingly, 1,080,958 (943,749–1,170,638) in adults older than 70<sup><a href="#ref-1">1</a></sup>. Globally, <i>Streptococcus pneumoniae</i> (pneumococcus)<i></i> was the leading cause of both morbidity and mortality among the LRTIs, contributing more deaths than all of the other studied etiologies combined (<i>Haemophilus influenzae</i> type b, influenza, and respiratory syncytial virus), and 1,189,937 deaths (95% UI 690,445–1,770,660) were attributed to the pneumococcus. The authors concluded that, although progress had been made in addressing the burden of LRTIs, it has not been equal across all locations and that more effort needed to be focused on the elderly since almost three quarters of LRTI deaths occurred in older children and adults, and the mortality rate is particularly high in those older than 70. Furthermore, the authors indicated that risk factors, including comorbidities, which put the elderly at risk of LRTIs, needed to be explored further. Moreover, the impact of the introduction of the pneumococcal conjugate vaccine (PCV) on the elderly in low- and middle-income countries in particular needed to be evaluated.</p><p class="" id=d4550e179>This review explores recent data regarding the global burden of <i>S. pneumoniae</i>, the changing recommendations for, and effects of, the introduction of PCV, particularly in childhood immunization programs but also in adults, and describes what is new on the horizon for future pneumococcal vaccination.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4550e188>Burden of pneumococcal disease</h2><p class="" id=d4550e191>There appears to be a changing burden of pneumococcal infection, at least in certain parts of the world, and such is the decline in the rate of pneumococcal infections that, in the US, this microorganism is now believed to account for less than 10 to 15% of cases of community-acquired pneumonia (CAP)<sup><a href="#ref-2">2</a></sup>. For example, in a 2015 active population-based surveillance of hospitalized CAP in adult patients in the US (EPIC Study), the most common pathogens were rhinovirus (9% of patients), influenza virus (6%) and the pneumococcus, which constituted 5% of the documented cases<sup><a href="#ref-3">3</a></sup>. In Europe, on the other hand, the proportion of cases due to the pneumococcus is higher than that reported for the US and has been attributed to differences in vaccine practices and the habit of smoking<sup><a href="#ref-2">2</a></sup>. For example, in a recent structured literature review that documented a varying but high burden of pneumococcal CAP in different countries in Europe, the burden occurred particularly among the elderly with comorbidities, despite the use of the 23-valent pneumococcal polysaccharide vaccine (PPV23)<sup><a href="#ref-4">4</a></sup>. The importance of comorbidities in the burden of pneumococcal infections has also been documented in the US, where rates of pneumococcal disease in at-risk and high-risk adults are much higher than in healthy adults<sup><a href="#ref-5">5</a></sup>.</p><p class="" id=d4550e214>One of the reasons that discrepancies exist in the frequencies of the documented etiologies in CAP in the different studies may relate to the definition of the etiology<sup><a href="#ref-6">6</a></sup>. Blood culture is often considered the “gold standard” of microbiological diagnosis in bacterial CAP but lacks sensitivity, and although commercially available urine antigen detection tests for the pneumococcus and <i>Legionella pneumophila</i> have better efficacy, they still have a sensitivity of only about 70 to 80%<sup><a href="#ref-6">6</a></sup>. Recent advances have been made in the molecular methods for the detection of putative pathogens; however, it has been said that these novel diagnostic methods are challenging in the absence of a true gold standard and that studies using strict case definitions, radiographic review, and application of these tests to control specimens may help elucidate their validity<sup><a href="#ref-6">6</a></sup>.</p><p class="" id=d4550e232>A recent study that evaluated the prevalence of pneumococcal pneumonia in patients hospitalized with CAP in Thailand used quantitative polymerase chain reaction of upper respiratory tract secretions and a commercially available urine antigen test (UAT) (BinaxNOW) together with Bayesian latent class modelling and conventional (BLCM) analysis<sup><a href="#ref-7">7</a></sup>. The BLCM analysis suggested a greater than 25% higher prevalence of pneumococcal pneumonia than that estimated by a conventional approach when assuming UAT to be the gold-standard reference test. In the EPIC Study, most of the pneumococcal infections were documented by using the BinaxNOW<sup><a href="#ref-3">3</a></sup>. However, when a novel serotype-specific urine antigen detection assay was applied to residual stored urine specimens from this study, it substantially increased the documentation of pneumococcal infection among the CAP cases, even though it diagnosed only serotypes contained in PCV13<sup><a href="#ref-8">8</a></sup>. Another prospective observational surveillance study of hospitalized CAP cases across 10 geographically dispersed cities in the US used cultures of the respiratory tract and normally sterile sites as well as the same serotype-specific urine antigen detection assay, and the authors concluded that, despite the uptake of PCV programs in children and associated herd protection in adults, there remained a persistent burden of PCV13-type CAP in the US<sup><a href="#ref-9">9</a></sup>.</p><p class="" id=d4550e251>Other studies and reviews published in the last four years from different parts of the world, including Australia<sup><a href="#ref-10">10</a>,<a href="#ref-11">11</a></sup> and the Asia Pacific region<sup><a href="#ref-12">12</a></sup>, Canada<sup><a href="#ref-13">13</a>,<a href="#ref-14">14</a></sup>, Latin America<sup><a href="#ref-15">15</a>–<a href="#ref-17">17</a></sup>, and the Caribbean<sup><a href="#ref-17">17</a></sup>, have documented similar findings. Namely, there is an ongoing high rate of pneumococcal pneumonia in all of these regions; in more recent years, this is often the case despite decreased rates associated with herd protection in adults from implementation of childhood PCV immunization as well as a residual burden of vaccine-serotype pneumonia and invasive pneumococcal disease (IPD), as described above.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4550e286>Pneumococcal vaccination</h2><p class="" id=d4550e289>A number of recent reviews of pneumococcal vaccination have described the differences between PPV23, the 23-valent polysaccharide vaccine, and PCV13, the 13-valent pneumococcal polysaccharide conjugate vaccine, the two vaccines that are registered for use in adults. These reviews recognize (i) the ability of the conjugate vaccine to inhibit carriage of vaccine serotypes in vaccinated children, resulting in not only direct protection but also indirect herd protection among unvaccinated children and adults<sup><a href="#ref-18">18</a></sup>, (ii) the importance of nasopharyngeal carriage and an understanding of the immunological mechanisms that confer protection against colonization and facilitate novel vaccine development and evaluation<sup><a href="#ref-19">19</a></sup>, and (iii) the need to study memory B-cell responses more intensively to fully understand long-term protection with PCV<sup><a href="#ref-20">20</a></sup>.</p><div class=section><a name=d4550e304 class=n-a></a><h3 class=section-title>Herd protection</h3><p class="" id=d4550e309>Introduction of the various conjugate vaccines into routine childhood vaccination programs, including PCV7<sup><a href="#ref-21">21</a>,<a href="#ref-22">22</a></sup>, PCV10<sup><a href="#ref-23">23</a>,<a href="#ref-24">24</a></sup>, and PCV13<sup><a href="#ref-25">25</a>–<a href="#ref-27">27</a></sup>, was shown to result in a decrease in serotype-specific IPD or pneumococcal pneumonia or both in the vaccinated individuals and adults, particularly the elderly, the latter via indirect herd protection. These include studies of PCV7<sup><a href="#ref-22">22</a></sup> and PCV10<sup><a href="#ref-24">24</a></sup> in low- and middle-income countries. Clearly, however, the results of additional studies from developing countries, several of which are ongoing, are necessary to accurately determine whether the impact of introduction of PCV is comparable to that in the developed world<sup><a href="#ref-28">28</a></sup>. The indirect effects of PCV on IPD or pneumococcal pneumonia (or both) in older adults appear to be dependent on PCV coverage rates, time from PCV implementation and differed according to the specific PCV used<sup><a href="#ref-29">29</a>,<a href="#ref-30">30</a></sup>.</p></div><div class=section><a name=d4550e354 class=n-a></a><h3 class=section-title>Serotype replacement disease</h3><p class="" id=d4550e359>It is clear from a myriad of recent single-country studies (Ireland<sup><a href="#ref-31">31</a></sup>, England and Wales<sup><a href="#ref-32">32</a></sup>, Japan<sup><a href="#ref-33">33</a></sup>, Canada<sup><a href="#ref-34">34</a>,<a href="#ref-35">35</a></sup>, and Portugal<sup><a href="#ref-36">36</a></sup>) and from surveys and systematic reviews/meta-analyses<sup><a href="#ref-37">37</a>,<a href="#ref-38">38</a></sup> that, with the progressive introduction of PCV in childhood immunization programs and the associated direct and indirect benefits of reducing vaccine serotype disease, serotype replacement disease/infection has also occurred in both children and adults, in some cases mainly in adults and especially in older adults. This has resulted from an increase in serotypes that are not covered by the specific vaccine introduced (for example, increase in unique PCV13 serotypes with introduction of PCV7 or increase in unique PPV23 serotypes, and non-vaccine serotypes [NVTs], after introduction of PCV13). Clearly, there are geographical differences in serotype replacement and there is a striking difference between the UK and the US<sup><a href="#ref-39">39</a></sup>. In the UK, as in Europe, NVT IPD has occurred mainly in older adults, whereas in the US NVT IPD has remained relatively stable in young children and older people. The authors contend that it is difficult to fully understand the reason (or reasons) for these differences since the circumstances in the two countries are otherwise very similar.</p><p class="" id=d4550e397>In some countries, such as Canada<sup><a href="#ref-35">35</a></sup> and Portugal<sup><a href="#ref-36">36</a></sup> and others<sup><a href="#ref-40">40</a></sup>, there has also been an increase in serotype 3 pneumococcal infection despite the introduction of PCV13, which contains serotype 3, and there is a lower efficacy of PCV13 in combatting serotype 3 as compared with other serotypes<sup><a href="#ref-40">40</a></sup>. These factors have led some of these authors to suggest that changes in vaccination strategies in adults need to be considered in order to build on the successes of PCVs in children, which are potentially being undermined by serotype replacement<sup><a href="#ref-31">31</a>,<a href="#ref-34">34</a>,<a href="#ref-37">37</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4550e430>Recommendations for vaccination in adults, including the elderly</h2><p class="" id=d4550e433>Currently, two vaccines are registered for use in adults, namely PPV23 and PCV13<sup><a href="#ref-41">41</a>,<a href="#ref-42">42</a></sup>. Recommendations have been made for their use on the basis of age and risk factors in adults, although changes in the exact recommendations and the dosing intervals have been made over the years, as reviewed elsewhere<sup><a href="#ref-41">41</a>–<a href="#ref-43">43</a></sup>. However, new changes in the recommendations were recently published by the Centers for Disease Control and Prevention (CDC) (US)<sup><a href="#ref-44">44</a></sup>. This relates primarily to the use of both PCV13 and PPV23 in adults who are at least 65 years old.</p><p class="" id=d4550e454>The earlier recommendation by the CDC for the dual use of these two vaccines in adults who are at least 65 years old<sup><a href="#ref-45">45</a></sup> was made in 2014 in recognition of the following: (i) despite herd protection in adults, there remained a residual burden of PCV13 serotype pneumococcal infection in adults; (ii) an increase in unique PPV23 serotype infection due to serotype replacement disease in adults; (iii) the importance of the burden of non-bacteremic pneumococcal pneumonia and new evidence from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA) that PCV13 was effective against non-bacteremic infections<sup><a href="#ref-46">46</a></sup>; (iv) data that suggested that although PPV23 was efficacious in preventing IPD among healthy young adults and generally healthy older individuals, studies of its efficacy in non-bacteremic infections were contradictory; and (v) acquisition of immunogenicity data supporting the use of PCV13 followed by PPV23 data (“prime boost” phenomenon), even in immunocompromised individuals<sup><a href="#ref-46">46</a>–<a href="#ref-49">49</a></sup>.</p><p class="" id=d4550e472>In the case of pneumococcal immunization, the recommended “prime boost” immunization strategy involves initial immunization with a single dose of PCV13 followed weeks or months later by a single dose of PPV23 in vaccine-naïve individuals. The perceived advantages of this strategy, investigated originally in vaccine-naïve elderly persons<sup><a href="#ref-48">48</a></sup>, are cost-effectiveness, maximizing the number of vaccine serotypes and augmentation of immunogenicity. Sadlier <i>et al.</i> have also demonstrated the efficacy of the PCV13/PPV23 “prime boost” immunization strategy in HIV-infected persons<sup><a href="#ref-47">47</a></sup>. In that study, HIV-infected persons (n = 64) were stratified to receive PCV13 followed 4 weeks later by PPV23 (n = 31 persons) or PPV23 at week 4 only (n = 33 persons). Measurement of serotype-specific IgG antibodies and functional opsonophagocytic antibodies was performed 8 and 28 weeks after administration of PPV23<sup><a href="#ref-47">47</a></sup>. The authors reported that the “prime boost” group was more likely to achieve increases of between two- and four-fold in the serum concentrations of serotype-specific and opsonophagocytic antibodies, respectively, at both time intervals tested<sup><a href="#ref-47">47</a></sup>.</p><p class="" id=d4550e494>Despite the apparent potential of the pneumococcal “prime boost” immunization strategy, several important concerns remain. These include (i) identifying the optimum interval between administration of PCV13 and PPV23, (ii) the duration of immunological protection, (iii) induction of immune hyporesponsiveness due to subsequent “boosting” with PPV23, (iv) failure of this strategy to induce persistent augmentation of protective antibody responses in clinical settings other than HIV infection<sup><a href="#ref-50">50</a></sup>, and (v) absence of compelling clinical trial data demonstrating efficacy in the prevention of severe pneumococcal infection.</p><p class="" id=d4550e502>Two opinion pieces were subsequently published in <i>JAMA Internal Medicine</i> by experts debating these recommendations, either supporting these recommendations or citing a potential lack of evidence for this recommendation, the complexity of the recommendations, and associated increased costs<sup><a href="#ref-51">51</a>,<a href="#ref-52">52</a></sup>. Nevertheless, it was recognized at that time that these recommendations would need to be re-looked at in the future as herd protection increased. This was done in 2019, when the recommendations of the CDC were again changed; the indication was that all adults at least 65 years of age should continue to receive PPV23 but that there should be shared decision making regarding preceding use of PCV13 in this age group among patients who do not have an immune-compromising condition, cerebrospinal fluid leak, cochlear implant, or increased risk of exposure to PCV 13 serotypes<sup><a href="#ref-44">44</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4550e522>Ongoing controversies in adult pneumococcal vaccination</h2><p class="" id=d4550e525>Nevertheless, there is still considerable debate about the best way to protect adults, including the elderly, against pneumococcal infection, and many questions need to be answered. There is also recognition that there are differences in different geographical regions with regard to both the residual burden of PCV-serotype disease following childhood vaccination and the extent of serotype replacement disease in both adults and children<sup><a href="#ref-53">53</a></sup>. As indicated previously, it is not completely clear why Europe and the US differ in both of these regards<sup><a href="#ref-53">53</a>,<a href="#ref-54">54</a></sup>. Furthermore, there needs to be a consideration of whether the herd protection of adults through childhood vaccination is as good a way of protecting adults as actively immunizing them<sup><a href="#ref-54">54</a>,<a href="#ref-55">55</a></sup>. It has even been suggested that some countries appear to have reached the limits of their herd protection<sup><a href="#ref-56">56</a></sup>, and a study from Switzerland even showed an increase in all-cause pneumonia and pneumococcal pneumonia in adults following introduction of pneumococcal vaccination in children<sup><a href="#ref-57">57</a></sup>.</p><p class="" id=d4550e554>There are additional issues that need to be addressed in the overall consideration of both PCV13 and PPV23 vaccination in adults. In this context, the ongoing incidence of PCV-serotype infections, particularly non-bacteremic infections, may be underestimated. For example, one study from Spain in immunocompetent adults hospitalized with CAP noted that infections with serotypes included in PCV13 still occurred commonly in both healthy individuals and those with underlying conditions, following introduction of PCV13, when this was diagnosed by using the serotype-specific UAT<sup><a href="#ref-58">58</a></sup>. Another study from Spain confirmed the value of the commercially available UAT to increase the detection rate of pneumococcal infections<sup><a href="#ref-59">59</a></sup>. In addition, while some have questioned the use of PPV23 in adults, largely because of possible hyporesponsiveness occurring after its use<sup><a href="#ref-60">60</a></sup>, this needs to be counterbalanced by recent studies indicating a potential benefit of PPV23 against both IPD and non-bacteremic pneumococcal infections<sup><a href="#ref-61">61</a>–<a href="#ref-63">63</a></sup>. Clearly, many factors influence the incidence of pneumococcal disease and the response to pneumococcal vaccination, including personal conditions, geographical and ethnic factors, and social risks, not all of which have been considered<sup><a href="#ref-64">64</a></sup>. Certainly, many countries have an aging population, and adults, both young and older with underlying medical conditions, have an increased risk of pneumococcal pneumonia and IPD<sup><a href="#ref-57">57</a>,<a href="#ref-65">65</a>,<a href="#ref-66">66</a></sup>, and although declines in pneumococcal disease have occurred in older adults and in those with comorbidities following the introduction of childhood PCV13 immunization, these declines have been attenuated<sup><a href="#ref-66">66</a></sup>. So the holy grail is, what is the future of adult pneumococcal vaccination<sup><a href="#ref-67">67</a></sup>?</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4550e603>New-generation pneumococcal conjugate vaccines</h2><p class="" id=d4550e606>Important concerns driving the development of new-generation PCVs include the following: <div class=list><a name=d4550e608 class=n-a></a><ul><li><p id=d4550e612>An increasing realization (as covered in detail above) that the extent of herd protection provided by existing vaccine coverage (PCV7/PCV13) appears to have plateaued in many geographic regions<sup><a href="#ref-56">56</a></sup>. This limitation of existing vaccines necessitates the development of novel extended-coverage PCVs to counter the threat posed by NVTs and also to potentiate the immunogenicity of the PCV13 serotypes 4, 19F, and 19A and serotype 3 in particular<sup><a href="#ref-56">56</a>,<a href="#ref-68">68</a></sup>. Although these novel vaccines will contribute to the efficacy of pneumococcal immunization programs in children, they are expected to offer considerable benefit to the elderly and other groups at high risk for the development of pneumonia and IPD. PCV15 and PCV20 are new-generation vaccines that fall into this category; the major beneficiaries of advances in pneumococcal immunization strategies have been children living in high-income countries where PCV7, PCV10, and PCV13 have been enthusiastically and effectively included in national childhood immunization programs. In many instances, children living in low-income countries have experienced similar benefit, largely through the efforts of the “Global Alliance for Vaccines and Immunization”, now known as “Gavi, the Vaccine Alliance”. This is an international philanthropic organization that, through negotiation and sponsorship, has enabled access to vaccines, including PCVs, for children living in some of the world’s poorest countries. However, in spite of these efforts, it has been estimated that 500,000 pneumococcal deaths occurred in children between 1 and 59 months of age in 2015<sup><a href="#ref-69">69</a>,<a href="#ref-70">70</a></sup>. Most of these deaths occurred in developing countries, and India, Nigeria, the Democratic Republic of Congo, and Pakistan accounted for 50% of these<sup><a href="#ref-69">69</a>,<a href="#ref-70">70</a></sup>. Mercifully, a more affordable new PCV10 targeting serotypes (1, 5 , 6A, 6B, 7F, 9V, 14, 19A, 19F, and 23F) of the pathogen, which are common in African and Asian countries, has been granted prequalification status (“facilitated access to medicines that meet the unified standards of quality, safety and efficacy”) by the World Health Organization<sup><a href="#ref-71">71</a></sup>. The vaccine, known as Pneumosil<sup>®</sup>, will be available to low- and middle-income countries.</p></li></ul></div></p><div class=section><a name=d4550e650 class=n-a></a><h3 class=section-title>PCV20</h3><p class="" id=d4550e655>Of the two third-generation extended-coverage PCVs (PCV15 and PCV20), the latter is in the most advanced stages of clinical evaluation (safety and immunogenicity). The vaccine was designed primarily for immunization of adults. In addition to the capsular polysaccharides present in PCV13, which are derived from serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F, the seven new serotypes contained in PCV20 are 8, 10A, 11A, 12F, 15 B/C, 22F, and 33F<sup><a href="#ref-72">72</a></sup>. Inclusion of the new serotypes confers additional protection against fatal disease (8, 10A, 11A, 15B/C, 22F, and 33F), infection with antibiotic-resistant strains of the pathogen (11A, 15B/C, 22F, and 33F), and meningitis (10A, 15B/C, 22F, and 33F)<sup><a href="#ref-72">72</a></sup>. PCV20 has successfully completed phase 1 and phase 2 clinical evaluations. The phase 1 trial (randomized, controlled observer-blind, two-arm parallel design) assessed the safety, tolerability, and immunogenicity in healthy, immunocompetent adult humans (n = 66) (age of 18 to 49 years) with no history of pneumococcal immunization<sup><a href="#ref-73">73</a></sup>. Participants were randomly assigned to receive a single intramuscular dose of PCV20 alone (n = 33) or a licensed combination of tetanus, diphtheria, cellular pertussis vaccine. Immunogenicity (opsonophagocytic antibody titers and concentrations of capsular-specific IgG antibodies) was measured 4 weeks post-immunization and the overall safety profile over 6 months<sup><a href="#ref-73">73</a></sup>. Impressive immunogenicity and safety were evident on completion of this trial.</p><p class="" id=d4550e674>The phase 2 trial included 444 vaccine-naïve, immunocompetent adults (age of 60 to 64 years) randomly assigned to receive either PCV13 or PCV20 (single intramuscular injection) followed by assessment of immunogenicity and safety<sup><a href="#ref-74">74</a></sup>. No safety concerns were evident, while immunogenicity was impressive and significant increases in opsonophagocytic antibody titers were detected for all capsular polysaccharides present in PCV20. Geometric mean fold increases from baseline of 6.1 to 68.6 and 9.0 to 112.2 were detected for antibodies targeting capsular polysaccharides present in PCV 13 only and for the additional capsular polysaccharides in PCV20, respectively<sup><a href="#ref-74">74</a></sup>. On the basis of these findings, the US Food and Drug Administration awarded “breakthrough therapy status” to PCV20 (expedited evaluation and development).</p><p class="" id=d4550e685>Subsequently, the Pfizer Vaccine R&amp;D Program has initiated three phase 3 clinical trials, all scheduled for completion in early 2020. Notwithstanding safety issues, the primary phase 3 trial (ClinicalTrials.gov Identifier: NCT03760146)<sup><a href="#ref-72">72</a></sup>, to which 3880 healthy, vaccine-naïve adults have been recruited, is focused on (i) a comparison of the immune responses to PCV20 and dual PCV13/PPV23 immunization in subjects at least 60 years old and (ii) the immunogenicity of PCV20 in persons 18 to 59 years old<sup><a href="#ref-72">72</a></sup>.</p><p class="" id=d4550e696>The second phase 3 trial (ClinicalTrials.gov Identifier: NCT03835975)<sup><a href="#ref-72">72</a></sup> is focused on the evaluation of safety and immunogenicity of PCV20 in elderly adults (n = 785, at least 65 years old) who had received prior immunization with PCV13 alone (≥6 months earlier) or with PPV23 alone (≥1 year to &lt;5 years earlier) or PCV13 followed by PPV23 (≥1 year earlier)<sup><a href="#ref-72">72</a></sup>.</p><p class="" id=d4550e708>In addition to providing additional safety data, the third phase 3 trial (ClinicalTrials.gov Identifier: NCT03828617)<sup><a href="#ref-72">72</a></sup>, to which 1610 adults (age of 18 to 49 years) with no history of pneumococcal immunization have been enrolled, is designed to evaluate the immunogenicity of three different lots of PCV20.</p><p class="" id=d4550e715>Considering estimates that about 79,000 of the 1.1 million cases of adults hospitalized with CAP in the US annually are caused by serotypes of the pneumococcus represented in PCV20, Thompson <i>et al.</i> recently proposed that a significant number of these cases may be prevented by immunization with this vaccine<sup><a href="#ref-73">73</a></sup>.</p></div><div class=section><a name=d4550e726 class=n-a></a><h3 class=section-title>PCV15</h3><p class="" id=d4550e731>The second third-generation PCV, PCV15, produced by Merck Vaccines, consists of the 13 pneumococcal serotypes present in PCV13 (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) together with the additional serotypes 22F and 33F<sup><a href="#ref-75">75</a></sup>, which (as mentioned above) are associated with infection caused by antibiotic-resistant strains of the pneumococcus as well as with severe disease, including meningitis. Unlike PCV20, which appears to target the prevention of severe pneumococcal disease in adults, PCV15 will be used in both the pediatric and adult settings. The safety and efficacy of PCV15 have been demonstrated in several phase 2 clinical trials undertaken in children<sup><a href="#ref-75">75</a></sup> and adults<sup><a href="#ref-76">76</a>,<a href="#ref-77">77</a></sup> and in a pre-clinical experimental animal study<sup><a href="#ref-78">78</a></sup>.</p><p class="" id=d4550e753>In a pediatric setting, Greenberg <i>et al.</i> recently reported the results of a multicenter (n = 58), phase 2 clinical trial (ClinicalTrials.gov Identifier: NCT01215188) encompassing five countries (US, Canada, Finland, Israel, and Spain) and 1148 healthy infants<sup><a href="#ref-75">75</a></sup>. Relative to the comparator vaccine (PCV13), PCV15 had an acceptable safety profile, and immunogenicity (four doses of vaccine administered at 2, 4, 6, 8, and 12 to 15 months of age) was also comparable to that of PCV13<sup><a href="#ref-75">75</a></sup>.</p><p class="" id=d4550e767>Two phase 2 trials undertaken by the same group investigated the safety and immunogenicity of PCV15 relative to those of PCV13 in adults<sup><a href="#ref-76">76</a></sup>. The first of these (ClinicalTrials.gov Identifier: NCT02547649), to which healthy adults (n = 690) younger than 50 years were enrolled, compared the safety and immunogenicity of PCV15 with those of PCV13, which were found to be comparable<sup><a href="#ref-76">76</a></sup>. The second study, to which adults (age of at least 65 years) who had previously been immunized with PPV23 were enrolled (n = 253), compared the safety and immunogenicity of PCV15 with those of PCV13<sup><a href="#ref-77">77</a></sup>. The authors reported that PCV15 was “generally well tolerated and induced high levels of IgG and opsonophagocytic antibodies to all 15 serotypes included in the vaccine when given as a single dose to adults at least 65 years of age previously vaccinated with PPV23”<sup><a href="#ref-77">77</a></sup>.</p><p class="" id=d4550e786>The authors of the aforementioned studies contend that PCV15 will provide necessary additional protection against the threat of IPD posed by serotypes 22F and 33F, which has emerged following the introduction of PCV13.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4550e793>Serotype-independent pneumococcal vaccines</h2><p class="" id=d4550e796>Despite the remarkable public health impact of PCVs in infant immunization, ongoing challenges persist, specifically those presented by serotype replacement with NVTs of the pneumococcus as well as the emergence of non-encapsulated strains of the pathogen. In the opinion of many experts, the development of vaccines based on highly conserved and immunogenic protein antigens remains the “holy grail” of universal pneumococcal immunization<sup><a href="#ref-79">79</a></sup>. Potential immunization strategies of this type include (i) vaccines based on single recombinant pneumococcal proteins or combinations of these, (ii) combining recombinant protein antigens with PCVs, and (iii) attenuated, non-encapsulated whole-cell vaccines, in which immunogenic surface proteins of the pathogen are exposed<sup><a href="#ref-80">80</a></sup>. An example of the latter type of vaccine is that derived from a non-proliferating and non-encapsulated strain of the pneumococcus (RM200 RXIE Pdt ΔlytA) in which the <i>lytA</i> (autolysin) and <i>ply</i> genes are deleted and inactivated, respectively<sup><a href="#ref-81">81</a></sup>.</p><p class="" id=d4550e817>However, to the best of our knowledge, no vaccine of any of the aforementioned types has progressed beyond the early stages of clinical evaluation. Two PCV/recombinant protein vaccines have reached phase 2 evaluation. These are (i) a vaccine based on PCV13 in combination with two recombinant pneumococcal proteins (pneumolysin toxoid and pneumococcal histidine triad protein D<sup><a href="#ref-82">82</a></sup>) and (ii) a variant of PCV10, known as PhiD-CV (which consists of serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, and 23F with eight capsular polysaccharides conjugated to protein D of non-typeable <i>H. influenzae</i> and the others to tetanus or diphtheria toxoid), in combination with the same two pneumococcal proteins<sup><a href="#ref-83">83</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4550e834>Conclusions</h2><p class="" id=d4550e837>The ongoing development and uptake of PCVs into national childhood immunization programs in many countries have impacted enormously on the public health threat posed by severe pneumococcal disease. Nevertheless, the burden of pneumococcal disease remains high in many countries, including those with compulsory childhood access to PCVs. Although a major contributing factor remains the limited serotype coverage provided by PCVs and the associated emergence of IPD caused by NVTs of the pneumococcus, other factors are also at play. These include recognition of disease caused by non-encapsulated strains of the pathogen, reaching the ceiling of herd protection, and the uncertainty surrounding the efficacy of current immunization practices in high-risk groups, compounded by global population aging and associated immunosenescence and comorbidity. Although expanded serotype coverage vaccines have been targeted for expedited approval, issues such as affordability and vaccine efficacy in the face of ongoing serotype replacement are likely to remain significant concerns. The search continues for a serotype-independent vaccine to counter the global burden of pneumococcal disease.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d4550e844 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d5075>References</h2><div class="section ref-list"><a name=d4550e844 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d4550e851 class=n-a></a>Troeger C, Blacker B, Khalil IA, <i> et al.</i>: Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. <i>Lancet Infect Dis.</i> 2018; <b>18</b>(11): 1191–210. <a target=xrefwindow id=d4550e862 href="http://www.ncbi.nlm.nih.gov/pubmed/30243584">PubMed Abstract </a> | <a target=xrefwindow id=d4550e865 href="https://doi.org/10.1016/S1473-3099(18)30310-4">Publisher Full Text </a> | <a target=xrefwindow id=d4550e869 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6202443">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d4550e878 class=n-a></a>Musher DM, Abers MS, Bartlett JG: Evolving Understanding of the Causes of Pneumonia in Adults, With Special Attention to the Role of Pneumococcus. <i>Clin Infect Dis.</i> 2017; <b>65</b>(10): 1736–44. <a target=xrefwindow id=d4550e886 href="http://www.ncbi.nlm.nih.gov/pubmed/29028977">PubMed Abstract </a> | <a target=xrefwindow id=d4550e889 href="https://doi.org/10.1093/cid/cix549">Publisher Full Text </a> | <a target=xrefwindow id=d4550e892 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7108120">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725633406"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e901 class=n-a></a>Jain S, Self WH, Wunderink RG, <i> et al.</i>: Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. <i>N Engl J Med.</i> 2015; <b>373</b>(5): 415–27. <a target=xrefwindow id=d4550e912 href="http://www.ncbi.nlm.nih.gov/pubmed/26172429">PubMed Abstract </a> | <a target=xrefwindow id=d4550e915 href="https://doi.org/10.1056/NEJMoa1500245">Publisher Full Text </a> | <a target=xrefwindow id=d4550e919 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4728150">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725633406">F1000 Recommendation</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d4550e932 class=n-a></a>Torres A, Cillóniz C, Blasi F, <i> et al.</i>: Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review. <i>Respir Med.</i> 2018; <b>137</b>: 6–13. <a target=xrefwindow id=d4550e943 href="http://www.ncbi.nlm.nih.gov/pubmed/29605214">PubMed Abstract </a> | <a target=xrefwindow id=d4550e946 href="https://doi.org/10.1016/j.rmed.2018.02.007">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d4550e955 class=n-a></a>Zhang D, Petigara T, Yang X: Clinical and economic burden of pneumococcal disease in US adults aged 19-64 years with chronic or immunocompromising diseases: an observational database study. <i>BMC Infect Dis.</i> 2018; <b>18</b>(1): 436. <a target=xrefwindow id=d4550e963 href="http://www.ncbi.nlm.nih.gov/pubmed/30157781">PubMed Abstract </a> | <a target=xrefwindow id=d4550e966 href="https://doi.org/10.1186/s12879-018-3326-z">Publisher Full Text </a> | <a target=xrefwindow id=d4550e969 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6116536">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d4550e979 class=n-a></a>Jain S, Pavia AT: <i>Editorial Commentary</i>: The Modern Quest for the "Holy Grail" of Pneumonia Etiology. <i>Clin Infect Dis.</i> 2016; <b>62</b>(7): 826–8. <a target=xrefwindow id=d4550e990 href="http://www.ncbi.nlm.nih.gov/pubmed/26747826">PubMed Abstract </a> | <a target=xrefwindow id=d4550e993 href="https://doi.org/10.1093/cid/civ1219">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735778075"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e1002 class=n-a></a>Lu Y, Joseph L, Bélisle P, <i> et al.</i>: Pneumococcal pneumonia prevalence among adults with severe acute respiratory illness in Thailand - comparison of Bayesian latent class modeling and conventional analysis. <i>BMC Infect Dis.</i> 2019; <b>19</b>(1): 423. <a target=xrefwindow id=d4550e1013 href="http://www.ncbi.nlm.nih.gov/pubmed/31092207">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1016 href="https://doi.org/10.1186/s12879-019-4067-3">Publisher Full Text </a> | <a target=xrefwindow id=d4550e1020 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6521483">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735778075">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d4550e1033 class=n-a></a>Wunderink RG, Self WH, Anderson EJ, <i> et al.</i>: Pneumococcal Community-Acquired Pneumonia Detected by Serotype-Specific Urinary Antigen Detection Assays. <i>Clin Infect Dis.</i> 2018; <b>66</b>(10): 1504–10. <a target=xrefwindow id=d4550e1044 href="http://www.ncbi.nlm.nih.gov/pubmed/29342250">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1047 href="https://doi.org/10.1093/cid/cix1066">Publisher Full Text </a> | <a target=xrefwindow id=d4550e1051 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5930250">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735738922"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e1060 class=n-a></a>Isturiz RE, Ramirez J, Self WH, <i> et al.</i>: Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia. <i>Vaccine.</i> 2019; <b>37</b>(25): 3352–61. <a target=xrefwindow id=d4550e1071 href="http://www.ncbi.nlm.nih.gov/pubmed/31072732">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1074 href="https://doi.org/10.1016/j.vaccine.2019.04.087">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735738922">F1000 Recommendation</a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d4550e1087 class=n-a></a>Earle K, Williams S: Burden of pneumococcal disease in adults aged 65 years and older: an Australian perspective. <i>Pneumonia (Nathan).</i> 2016; <b>8</b>: 9. <a target=xrefwindow id=d4550e1095 href="http://www.ncbi.nlm.nih.gov/pubmed/28702288">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1098 href="https://doi.org/10.1186/s41479-016-0008-8">Publisher Full Text </a> | <a target=xrefwindow id=d4550e1101 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5471924">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d4550e1110 class=n-a></a>Yin JK, Jayasinghe SH, Charles PG, <i> et al.</i>: Determining the contribution of <i>Streptococcus pneumoniae</i> to community-acquired pneumonia in Australia. <i>Med J Aust.</i> 2017; <b>207</b>(9): 396–400. <a target=xrefwindow id=d4550e1124 href="https://doi.org/10.5694/mja16.01102">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d4550e1134 class=n-a></a>Song JH, Huh K, Chung DR: Community-Acquired Pneumonia in the Asia-Pacific Region. <i>Semin Respir Crit Care Med.</i> 2016; <b>37</b>(6): 839–54. <a target=xrefwindow id=d4550e1142 href="http://www.ncbi.nlm.nih.gov/pubmed/27960208">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1145 href="https://doi.org/10.1055/s-0036-1592075">Publisher Full Text </a> | <a target=xrefwindow id=d4550e1148 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7171710">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d4550e1157 class=n-a></a>McNeil SA, Qizilbash N, Ye J, <i> et al.</i>: A Retrospective Study of the Clinical Burden of Hospitalized All-Cause and Pneumococcal Pneumonia in Canada. <i>Can Respir J.</i> 2016; <b>2016</b>: 3605834. <a target=xrefwindow id=d4550e1168 href="http://www.ncbi.nlm.nih.gov/pubmed/27445530">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1171 href="https://doi.org/10.1155/2016/3605834">Publisher Full Text </a> | <a target=xrefwindow id=d4550e1175 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4904510">Free Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d4550e1184 class=n-a></a>LeBlanc JJ, ElSherif M, Ye L, <i> et al.</i>: Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study. <i>Vaccine.</i> 2017; <b>35</b>(29): 3647–54. <a target=xrefwindow id=d4550e1195 href="http://www.ncbi.nlm.nih.gov/pubmed/28554501">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1198 href="https://doi.org/10.1016/j.vaccine.2017.05.049">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d4550e1207 class=n-a></a>Iannella H, Luna CM: Community-acquired pneumonia in Latin America. <i>Semin Respir Crit Care Med.</i> 2016; <b>37</b>(6): 868–75. <a target=xrefwindow id=d4550e1215 href="http://www.ncbi.nlm.nih.gov/pubmed/27960210">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1218 href="https://doi.org/10.1055/s-0036-1592076">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d4550e1227 class=n-a></a>Michelin L, Weber FM, Scolari BW, <i> et al.</i>: Mortality and costs of pneumococcal pneumonia in adults: a cross-sectional study. <i>J Bras Pneumol.</i> 2019; <b>45</b>(6): e20180374. <a target=xrefwindow id=d4550e1238 href="http://www.ncbi.nlm.nih.gov/pubmed/31644703">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1241 href="https://doi.org/10.1590/1806-3713/e20180374">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d4550e1250 class=n-a></a>De la Hoz Restrepo F, Loo JD, Carvalho AF, <i> et al.</i>: The burden of pneumococcal disease in older children and adults in Latin America and the Caribbean. Sabin Vaccine Institute, 2018. <a target=xrefwindow id=d4550e1255 href="https://www.sabin.org/sites/sabin.org/files/resources/adult_pneumococcal_report.pdf">Reference Source</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d4550e1265 class=n-a></a>Jochems SP, Weiser JN, Malley R, <i> et al.</i>: The immunological mechanisms that control pneumococcal carriage. <i>PLoS Pathog.</i> 2017; <b>13</b>(12): e1006665. <a target=xrefwindow id=d4550e1276 href="http://www.ncbi.nlm.nih.gov/pubmed/29267378">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1279 href="https://doi.org/10.1371/journal.ppat.1006665">Publisher Full Text </a> | <a target=xrefwindow id=d4550e1283 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5739485">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d4550e1292 class=n-a></a>Croucher NJ, Løchen A, Bentley SD: Pneumococcal Vaccines: Host Interactions, Population Dynamics, and Design Principles. <i>Annu Rev Microbiol.</i> 2018; <b>72</b>: 521–49. <a target=xrefwindow id=d4550e1300 href="http://www.ncbi.nlm.nih.gov/pubmed/30200849">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1303 href="https://doi.org/10.1146/annurev-micro-090817-062338">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734960081"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e1312 class=n-a></a>Papadatou I, Tzovara I, Licciardi PV: The Role of Serotype-Specific Immunological Memory in Pneumococcal Vaccination: Current Knowledge and Future Prospects. <i>Vaccines (Basel).</i> 2019; <b>7</b>(1): pii: E13. <a target=xrefwindow id=d4550e1320 href="http://www.ncbi.nlm.nih.gov/pubmed/30700048">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1323 href="https://doi.org/10.3390/vaccines7010013">Publisher Full Text </a> | <a target=xrefwindow id=d4550e1326 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6466264">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734960081">F1000 Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d4550e1339 class=n-a></a>Myint TT, Madhava H, Balmer P, <i> et al.</i>: The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review. <i>Adv Ther.</i> 2013; <b>30</b>(2): 127–51. <a target=xrefwindow id=d4550e1350 href="http://www.ncbi.nlm.nih.gov/pubmed/23397399">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1353 href="https://doi.org/10.1007/s12325-013-0007-6">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d4550e1362 class=n-a></a>von Gottberg A, de Gouveia L, Tempia S, <i> et al.</i>: Effects of vaccination on invasive pneumococcal disease in South Africa. <i>N Engl J Med.</i> 2014; <b>371</b>(20): 1889–99. <a target=xrefwindow id=d4550e1373 href="http://www.ncbi.nlm.nih.gov/pubmed/25386897">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1376 href="https://doi.org/10.1056/NEJMoa1401914">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d4550e1385 class=n-a></a>Quirk SJ, Haraldsson G, Hjálmarsdóttir MÁ, <i> et al.</i>: Vaccination of Icelandic Children with the 10-Valent Pneumococcal Vaccine Leads to a Significant Herd Effect among Adults in Iceland. <i>J Clin Microbiol.</i> 2019; <b>57</b>(4): pii: e01766-18. <a target=xrefwindow id=d4550e1396 href="http://www.ncbi.nlm.nih.gov/pubmed/30651396">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1399 href="https://doi.org/10.1128/JCM.01766-18">Publisher Full Text </a> | <a target=xrefwindow id=d4550e1403 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6440763">Free Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d4550e1413 class=n-a></a>Hammitt LL, Etyang AO, Morpeth SC, <i> et al.</i>: Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study. <i>Lancet.</i> 2019; <b>393</b>(10186): 2146–54. <a target=xrefwindow id=d4550e1424 href="http://www.ncbi.nlm.nih.gov/pubmed/31000194">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1427 href="https://doi.org/10.1016/S0140-6736(18)33005-8">Publisher Full Text </a> | <a target=xrefwindow id=d4550e1431 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6548991">Free Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d4550e1440 class=n-a></a>Rodrigo C, Bewick T, Sheppard C, <i> et al.</i>: Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia. <i>Eur Respir J.</i> 2015; <b>45</b>(6): 1632–41. <a target=xrefwindow id=d4550e1451 href="http://www.ncbi.nlm.nih.gov/pubmed/25792633">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1454 href="https://doi.org/10.1183/09031936.00183614">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725348306"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e1463 class=n-a></a>Moore MR, Link-Gelles R, Schaffner W, <i> et al.</i>: Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. <i>Lancet Infect Dis.</i> 2015; <b>15</b>(3): 301–9. <a target=xrefwindow id=d4550e1474 href="http://www.ncbi.nlm.nih.gov/pubmed/25656600">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1477 href="https://doi.org/10.1016/S1473-3099(14)71081-3">Publisher Full Text </a> | <a target=xrefwindow id=d4550e1481 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4876855">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725348306">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d4550e1494 class=n-a></a>Sando E, Suzuki M, Furumoto A, <i> et al.</i>: Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE). <i>Vaccine.</i> 2019; <b>37</b>(20): 2687–93. <a target=xrefwindow id=d4550e1505 href="http://www.ncbi.nlm.nih.gov/pubmed/30975569">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1508 href="https://doi.org/10.1016/j.vaccine.2019.04.009">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735994812"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e1517 class=n-a></a>Murdoch DR: Assessing the Impact of Pneumococcal Conjugate Vaccines. <i>Clin Infect Dis.</i> 2020; <b>70</b>(8): 1589–1590. <a target=xrefwindow id=d4550e1525 href="http://www.ncbi.nlm.nih.gov/pubmed/31175809">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1528 href="https://doi.org/10.1093/cid/ciz484">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735994812">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d4550e1541 class=n-a></a>Tsaban G, Ben-Shimol S: Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature. <i>Vaccine.</i> 2017; <b>35</b>(22): 2882–91. <a target=xrefwindow id=d4550e1549 href="http://www.ncbi.nlm.nih.gov/pubmed/28449971">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1552 href="https://doi.org/10.1016/j.vaccine.2017.04.032">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d4550e1562 class=n-a></a>Hanquet G, Krizova P, Valentiner-Branth P, <i> et al.</i>: Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination. <i>Thorax.</i> 2019; <b>74</b>(5): 473–82. <a target=xrefwindow id=d4550e1573 href="http://www.ncbi.nlm.nih.gov/pubmed/30355641">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1576 href="https://doi.org/10.1136/thoraxjnl-2018-211767">Publisher Full Text </a> | <a target=xrefwindow id=d4550e1580 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6484683">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d4550e1589 class=n-a></a>Corcoran M, Vickers I, Mereckiene J, <i> et al.</i>: The epidemiology of invasive pneumococcal disease in older adults in the post-PCV era. Has there been a herd effect? <i>Epidemiol Infect.</i> 2017; <b>145</b>(11): 2390–9. <a target=xrefwindow id=d4550e1600 href="http://www.ncbi.nlm.nih.gov/pubmed/28712384">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1603 href="https://doi.org/10.1017/S0950268817001194">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d4550e1612 class=n-a></a>Ladhani SN, Collins S, Djennad A, <i> et al.</i>: Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study. <i>Lancet Infect Dis.</i> 2018; <b>18</b>(4): 441–51. <a target=xrefwindow id=d4550e1623 href="http://www.ncbi.nlm.nih.gov/pubmed/29395999">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1626 href="https://doi.org/10.1016/S1473-3099(18)30052-5">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d4550e1635 class=n-a></a>Katoh S, Suzuki M, Ariyoshi K, <i> et al.</i>: Serotype replacement in adult pneumococcal pneumonia after the introduction of seven-valent pneumococcal conjugate vaccines for children in Japan: a systematic literature review and pooled data analysis. <i>Jpn J Infect Dis.</i> 2017; <b>70</b>(5): 495–501. <a target=xrefwindow id=d4550e1646 href="http://www.ncbi.nlm.nih.gov/pubmed/28367876">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1649 href="https://doi.org/10.7883/yoken.JJID.2016.311">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d4550e1658 class=n-a></a>Desai S, Policarpio ME, Wong K, <i> et al.</i>: The epidemiology of invasive pneumococcal disease in older adults from 2007 to 2014 in Ontario, Canada: a population-based study. <i>CMAJ Open.</i> 2016; <b>4</b>(3): E545–E550. <a target=xrefwindow id=d4550e1669 href="http://www.ncbi.nlm.nih.gov/pubmed/27730119">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1672 href="https://doi.org/10.9778/cmajo.20160035">Publisher Full Text </a> | <a target=xrefwindow id=d4550e1676 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5047806">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d4550e1685 class=n-a></a>Wijayasri S, Hillier K, Lim GH, <i> et al.</i>: The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017. <i>PLoS One.</i> 2019; <b>14</b>(12): e0226353. <a target=xrefwindow id=d4550e1696 href="http://www.ncbi.nlm.nih.gov/pubmed/31834926">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1699 href="https://doi.org/ 10.1371/journal.pone.0226353">Publisher Full Text </a> | <a target=xrefwindow id=d4550e1703 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6910703">Free Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d4550e1713 class=n-a></a>Horácio AN, Silva-Costa C, Lopes JP, <i> et al.</i>: Serotype 3 remains the leading cause of invasive pneumococcal disease in adults in Portugal (2012-2014) despite continued reductions in other 13-valent conjugate vaccine serotypes. <i>Front Microbiol.</i> 2016; <b>7</b>: 1616. <a target=xrefwindow id=d4550e1724 href="http://www.ncbi.nlm.nih.gov/pubmed/27790208">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1727 href="https://doi.org/10.3389/fmicb.2016.01616">Publisher Full Text </a> | <a target=xrefwindow id=d4550e1731 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5064670">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d4550e1740 class=n-a></a>Izurieta P, Bahety P, Adegbola R, <i> et al.</i>: Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution. <i>Expert Rev Vaccines.</i> 2018; <b>17</b>(6): 479–93. <a target=xrefwindow id=d4550e1751 href="http://www.ncbi.nlm.nih.gov/pubmed/29241390">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1754 href="https://doi.org/10.1080/14760584.2018.1413354">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d4550e1763 class=n-a></a>Vadlamudi NK, Chen A, Marra F: Impact of the 13-valent pneumococcal conjugate vaccine among adults: a systematic review and meta-analysis. <i>Clin Infect Dis.</i> 2019; <b>69</b>(1): 34–49. <a target=xrefwindow id=d4550e1771 href="http://www.ncbi.nlm.nih.gov/pubmed/30312379">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1774 href="https://doi.org/10.1093/cid/ciy872">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734940142"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e1783 class=n-a></a>Lewnard JA, Hanage WP: Making sense of differences in pneumococcal serotype replacement. <i>Lancet Infect Dis.</i> 2019; <b>19</b>(6): e213–e220. <a target=xrefwindow id=d4550e1791 href="http://www.ncbi.nlm.nih.gov/pubmed/30709666">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1794 href="https://doi.org/10.1016/S1473-3099(18)30660-1">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734940142">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734891274"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e1807 class=n-a></a>Linley E, Bell A, Gritzfeld JF, <i> et al.</i>: Should pneumococcal serotype 3 be included in serotype-specific immunoassays? <i>Vaccines (Basel).</i> 2019; <b>7</b>(1): pii: E4. <a target=xrefwindow id=d4550e1818 href="http://www.ncbi.nlm.nih.gov/pubmed/30609868">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1821 href="https://doi.org/10.3390/vaccines7010004">Publisher Full Text </a> | <a target=xrefwindow id=d4550e1825 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6466091">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734891274">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d4550e1838 class=n-a></a>Kobayashi M, Bennett NM, Gierke R, <i> et al.</i>: Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). <i>MMWR Morb Mortal Wkly Rep.</i> 2015; <b>64</b>(34): 944–7. <a target=xrefwindow id=d4550e1849 href="http://www.ncbi.nlm.nih.gov/pubmed/26334788">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1852 href="https://doi.org/10.15585/mmwr.mm6434a4">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d4550e1862 class=n-a></a>Berical AC, Harris D, Dela Cruz CS, <i> et al.</i>: Pneumococcal vaccination strategies. an update and perspective. <i>Ann Am Thorac Soc.</i> 2016; <b>13</b>(6): 933–44. <a target=xrefwindow id=d4550e1873 href="http://www.ncbi.nlm.nih.gov/pubmed/27088424">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1876 href="https://doi.org/10.1513/AnnalsATS.201511-778FR">Publisher Full Text </a> | <a target=xrefwindow id=d4550e1880 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5461988">Free Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d4550e1889 class=n-a></a>Perez F, Jump RL: New developments in adult vaccination: Challenges and opportunities to protect vulnerable veterans from pneumococcal disease. <i> Fed Pract.</i> 2015; <b>32</b>(12): 12–19. <a target=xrefwindow id=d4550e1897 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6366312">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736951489"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e1906 class=n-a></a>Matanock A, Lee G, Gierke R, <i> et al.</i>: Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: updated recommendations of the Advisory Committee on Immunization Practices. <i>MMWR Morb Mortal Wkly Rep.</i> 2019; <b>68</b>(46): 1069–75. <a target=xrefwindow id=d4550e1917 href="http://www.ncbi.nlm.nih.gov/pubmed/31751323">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1920 href="https://doi.org/10.15585/mmwr.mm6846a5">Publisher Full Text </a> | <a target=xrefwindow id=d4550e1924 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6871896">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736951489">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d4550e1937 class=n-a></a>Tomczyk S, Bennett NM, Stoecker C, <i> et al.</i>: Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). <i>MMWR Morb Mortal Wkly Rep.</i> 2014; <b>63</b>(37): 822–5. <a target=xrefwindow id=d4550e1948 href="http://www.ncbi.nlm.nih.gov/pubmed/25233284">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1951 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5779453">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d4550e1960 class=n-a></a>Pilishvili T, Bennett NM: Pneumococcal disease prevention among adults: strategies for the use of pneumococcal vaccines. <i>Am J Prev Med.</i> 2015; <b>49</b>(6 Suppl 4): S383–90. <a target=xrefwindow id=d4550e1968 href="http://www.ncbi.nlm.nih.gov/pubmed/26590438">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1971 href="https://doi.org/10.1016/j.amepre.2015.09.008">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d4550e1980 class=n-a></a>Sadlier C, O'Dea S, Bennett K, <i> et al.</i>: Immunological efficacy of pneumococcal vaccine strategies in HIV-infected adults: a randomized clinical trial. <i>Sci Rep.</i> 2016; <b>6</b>: 32076. <a target=xrefwindow id=d4550e1991 href="http://www.ncbi.nlm.nih.gov/pubmed/27580688">PubMed Abstract </a> | <a target=xrefwindow id=d4550e1994 href="https://doi.org/10.1038/srep32076">Publisher Full Text </a> | <a target=xrefwindow id=d4550e1998 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5007521">Free Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d4550e2008 class=n-a></a>Greenberg RN, Gurtman A, Frenck RW, <i> et al.</i>: Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60-64 years of age. <i>Vaccine.</i> 2014; <b>32</b>(20): 2364–74. <a target=xrefwindow id=d4550e2019 href="http://www.ncbi.nlm.nih.gov/pubmed/24606865">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2022 href="https://doi.org/10.1016/j.vaccine.2014.02.002">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d4550e2031 class=n-a></a>Jackson LA, Gurtman A, van Cleeff M, <i> et al.</i>: Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults. <i>Vaccine.</i> 2013; <b>31</b>(35): 3577–84. <a target=xrefwindow id=d4550e2042 href="http://www.ncbi.nlm.nih.gov/pubmed/23688526">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2045 href="https://doi.org/10.1016/j.vaccine.2013.04.085">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d4550e2054 class=n-a></a>Bahuaud M, Beaudouin-Bazire C, Husson M, <i> et al.</i>: Immunogenicity and persistence of a prime-boost re-vaccination strategy for pneumococcal vaccines in patients with rheumatoid arthritis. <i>Hum Vaccin Immunother.</i> 2018; <b>14</b>(6): 1464–70. <a target=xrefwindow id=d4550e2065 href="http://www.ncbi.nlm.nih.gov/pubmed/29432051">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2068 href="https://doi.org/10.1080/21645515.2018.1438091">Publisher Full Text </a> | <a target=xrefwindow id=d4550e2072 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6037436">Free Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d4550e2081 class=n-a></a>Schuchat A: Pneumococcal prevention gets older and wiser. <i>JAMA Intern Med.</i> 2015; <b>175</b>(12): 1897–8. <a target=xrefwindow id=d4550e2089 href="http://www.ncbi.nlm.nih.gov/pubmed/26502379">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2092 href="https://doi.org/10.1001/jamainternmed.2015.6133">Publisher Full Text </a> | <a target=xrefwindow id=d4550e2095 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5729895">Free Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d4550e2104 class=n-a></a>Hochman M, Cohen PA: Reconsidering guidelines on the use of pneumococcal vaccines in adults 65 years or older. <i>JAMA Intern Med.</i> 2015; <b>175</b>(12): 1895–6. <a target=xrefwindow id=d4550e2112 href="http://www.ncbi.nlm.nih.gov/pubmed/26502317">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2115 href="https://doi.org/10.1001/jamainternmed.2015.5689">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735712864"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e2124 class=n-a></a>van der Linden M, Whitney CG: Herd protection or herding cats? <i>Thorax.</i> 2019; <b>74</b>(5): 425–6. <a target=xrefwindow id=d4550e2132 href="http://www.ncbi.nlm.nih.gov/pubmed/30842254">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2135 href="https://doi.org/10.1136/thoraxjnl-2018-212585">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735712864">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736919248"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e2149 class=n-a></a>Weinberger DM, Shapiro ED: Prevention of pneumococcal infections in adults using conjugate vaccines: no easy answers. <i>Clin Infect Dis.</i> 2019; <b>69</b>(1): 50–1. <a target=xrefwindow id=d4550e2157 href="http://www.ncbi.nlm.nih.gov/pubmed/30312380">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2160 href="https://doi.org/10.1093/cid/ciy873">Publisher Full Text </a> | <a target=xrefwindow id=d4550e2163 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6579952">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736919248">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d4550e2176 class=n-a></a>Prato R, Fortunato F, Martinelli D: Pneumococcal pneumonia prevention among adults: is the herd effect of pneumococcal conjugate vaccination in children as good a way as the active immunization of the elderly? <i>Curr Med Res Opin.</i> 2015; <b>32</b>(3): 543–5. <a target=xrefwindow id=d4550e2184 href="http://www.ncbi.nlm.nih.gov/pubmed/26652736">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2187 href="https://doi.org/10.1185/03007995.2015.1131150">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736322626"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e2196 class=n-a></a>van der Linden M, Imöhl M, Perniciaro S: Limited indirect effects of an infant pneumococcal vaccination program in an aging population. <i>PLoS One.</i> 2019; <b>14</b>(8): e0220453. <a target=xrefwindow id=d4550e2204 href="http://www.ncbi.nlm.nih.gov/pubmed/31369597">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2207 href="https://doi.org/10.1371/journal.pone.0220453">Publisher Full Text </a> | <a target=xrefwindow id=d4550e2210 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6675109">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736322626">F1000 Recommendation</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/737129530"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e2223 class=n-a></a>Albrich WC, Rassouli F, Waldeck F, <i> et al.</i>: Influence of older age and other risk factors on pneumonia hospitalization in Switzerland in the pneumococcal vaccine era. <i>Front Med (Lausanne).</i> 2019; <b>6</b>: 286. <a target=xrefwindow id=d4550e2234 href="http://www.ncbi.nlm.nih.gov/pubmed/31867337">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2237 href="https://doi.org/10.3389/fmed.2019.00286">Publisher Full Text </a> | <a target=xrefwindow id=d4550e2241 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6906144">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/737129530">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d4550e2254 class=n-a></a>Menéndez R, España PP, Pérez-Trallero E, <i> et al.</i>: The burden of PCV13 serotypes in hospitalized pneumococcal pneumonia in Spain using a novel urinary antigen detection test. CAPA study. <i>Vaccine.</i> 2017; <b>35</b>(39): 5264–70. <a target=xrefwindow id=d4550e2265 href="http://www.ncbi.nlm.nih.gov/pubmed/28823622">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2268 href="https://doi.org/10.1016/j.vaccine.2017.08.007">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d4550e2277 class=n-a></a>Ceccato A, Torres A, Cilloniz C, <i> et al.</i>: Invasive disease vs urinary antigen-confirmed pneumococcal community-acquired pneumonia. <i>Chest.</i> 2017; <b>151</b>(6): 1311–9. <a target=xrefwindow id=d4550e2288 href="http://www.ncbi.nlm.nih.gov/pubmed/28093269">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2291 href="https://doi.org/10.1016/j.chest.2017.01.005">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d4550e2301 class=n-a></a>Papadatou I, Spoulou V, Papasian CJ: Pneumococcal vaccination in high-risk individuals: are we doing it right? <i>Clin Vaccine Immunol.</i> 2016; <b>23</b>(5): 388–95. <a target=xrefwindow id=d4550e2309 href="http://www.ncbi.nlm.nih.gov/pubmed/27009210">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2312 href="https://doi.org/10.1128/CVI.00721-15">Publisher Full Text </a> | <a target=xrefwindow id=d4550e2315 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4860474">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d4550e2324 class=n-a></a>Falkenhorst G, Remschmidt C, Harder T, <i> et al.</i>: Effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPV23) against pneumococcal disease in the elderly: systematic review and meta-analysis. <i>PLoS One.</i> 2017; <b>12</b>(1): e0169368. <a target=xrefwindow id=d4550e2335 href="http://www.ncbi.nlm.nih.gov/pubmed/28061505">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2338 href="https://doi.org/10.1371/journal.pone.0169368">Publisher Full Text </a> | <a target=xrefwindow id=d4550e2342 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5218810">Free Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d4550e2351 class=n-a></a>Djennad A, Ramsay ME, Pebody R, <i> et al.</i>: Effectiveness of 23-valent polysaccharide pneumococcal vaccine and changes in invasive pneumococcal disease incidence from 2000 to 2017 in those aged 65 and over in England and Wales. <i>EClinicalMedicine.</i> 2019; <b>6</b>: 42–50. <a target=xrefwindow id=d4550e2362 href="http://www.ncbi.nlm.nih.gov/pubmed/31193709">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2365 href="https://doi.org/10.1016/j.eclinm.2018.12.007">Publisher Full Text </a> | <a target=xrefwindow id=d4550e2369 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6537583">Free Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d4550e2378 class=n-a></a>Kim JH, Chun BC, Song JY, <i> et al.</i>: Direct effectiveness of pneumococcal polysaccharide vaccine against invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia in elderly population in the era of pneumococcal conjugate vaccine: a case-control study. <i>Vaccine.</i> 2019; <b>37</b>(21): 2797–804. <a target=xrefwindow id=d4550e2389 href="http://www.ncbi.nlm.nih.gov/pubmed/31005428">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2392 href="https://doi.org/10.1016/j.vaccine.2019.04.017">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735578797"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e2401 class=n-a></a>Park SB, Kim HJ, Cheong HJ: Environmental factors which can affect the burden of pneumococcal disease and the immune response to pneumococcal vaccines: the need for more precisely delineated vaccine recommendations. <i>Expert Rev Vaccines.</i> 2019; <b>18</b>(6): 587–96. <a target=xrefwindow id=d4550e2409 href="http://www.ncbi.nlm.nih.gov/pubmed/30998430">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2412 href="https://doi.org/10.1080/14760584.2019.1607303">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735578797">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d4550e2425 class=n-a></a>Imai K, Petigara T, Kohn MA, <i> et al.</i>: Risk of pneumococcal diseases in adults with underlying medical conditions: a retrospective, cohort study using two Japanese healthcare databases. <i>BMJ Open.</i> 2018; <b>8</b>(3): e018553. <a target=xrefwindow id=d4550e2436 href="http://www.ncbi.nlm.nih.gov/pubmed/29500201">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2439 href="https://doi.org/10.1136/bmjopen-2017-018553">Publisher Full Text </a> | <a target=xrefwindow id=d4550e2443 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5855349">Free Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734054428"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e2453 class=n-a></a>Pelton SI, Bornheimer R, Doroff R, <i> et al.</i>: Decline in Pneumococcal disease attenuated in older adults and those with comorbidities following universal childhood PCV13 immunization. <i>Clin Infect Dis.</i> 2019; <b>68</b>(11): 1831–8. <a target=xrefwindow id=d4550e2464 href="http://www.ncbi.nlm.nih.gov/pubmed/30239637">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2467 href="https://doi.org/10.1093/cid/ciy800">Publisher Full Text </a> | <a target=xrefwindow id=d4550e2471 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6522679">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734054428">F1000 Recommendation</a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736868763"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e2484 class=n-a></a>Weinberger DM, Shapiro ED: Pneumococcal vaccines for adults: what’s next? <i>Clin Infect Dis.</i> 2019; pii: ciz743. <a target=xrefwindow id=d4550e2489 href="http://www.ncbi.nlm.nih.gov/pubmed/31402388">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2492 href="https://doi.org/10.1093/cid/ciz743">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736868763">F1000 Recommendation</a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736931954"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e2505 class=n-a></a>Goettler D, Streng A, Kemmling D, <i> et al.</i>: Increase in <i>Streptococcus pneumoniae</i> serotype 3 associated parapneumonic pleural effusion/empyema after the introduction of PCV13 in Germany. <i>Vaccine.</i> 2020; <b>38</b>(3): 570–7. <a target=xrefwindow id=d4550e2519 href="http://www.ncbi.nlm.nih.gov/pubmed/31735502">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2523 href="https://doi.org/10.1016/j.vaccine.2019.10.056">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736931954">F1000 Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d4550e2537 class=n-a></a>Centers for Disease Control and Prevention (CDC): Global Pneumococcal Disease and Vaccine. Accessed 23 Jan 2020.<a target=xrefwindow id=d4550e2539 href="https://www.cdc.gov/pneumococcal/global.html">Reference Source</a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d4550e2548 class=n-a></a>Wahl B, O'Brien KL, Greenbaum A, <i> et al.</i>: Burden of <i>Streptococcus pneumoniae</i> and <i>Haemophilus influenzae</i> type b disease in children in the era of conjugate vaccines: Global, regional, and national estimates for 2000-15. <i>Lancet Glob Health.</i> 2018; <b>6</b>(7): e744–e757. <a target=xrefwindow id=d4550e2566 href="http://www.ncbi.nlm.nih.gov/pubmed/29903376">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2569 href="https://doi.org/10.1016/S2214-109X(18)30247-X">Publisher Full Text </a> | <a target=xrefwindow id=d4550e2572 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6005122">Free Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d4550e2581 class=n-a></a>Serum Institute of India: New pneumococcal vaccine from Serum Institute of India achieves WHO prequalification. Accessed 9 Jan 2020. <a target=xrefwindow id=d4550e2583 href="https://www.path.org/media-center/new-pneumococcal-vaccine-serum-institute-india-achieves-who-prequalification/">Reference Source</a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d4550e2593 class=n-a></a>Pfizer Inc: Pfizer announces serotypes included in 20-valent pneumococcal conjugate vaccine candidate being investigated for the prevention of invasive disease and pneumonia in adults aged 18 years and older. Accessed 21 Jan 2020. <a target=xrefwindow id=d4550e2595 href="https://investors.pfizer.com/investor-news/press-release-details/2019/Pfizer-Announces-Serotypes-Included-in-20-Valent-Pneumococcal-Conjugate-Vaccine-Candidate-Being-Investigated-for-the-Prevention-of-Invasive-Disease-and-Pneumonia-in-Adults-Aged-18-Years-and-Older/default.aspx">Reference Source</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d4550e2604 class=n-a></a>Thompson A, Lamberth E, Severs J, <i> et al.</i>: Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults. <i>Vaccine.</i> 2019; <b>37</b>(42): 6201–7. <a target=xrefwindow id=d4550e2615 href="https://doi.org/10.1016/j.vaccine.2019.08.048">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d4550e2624 class=n-a></a>Watson, W, Hurley D, <i> et al.</i>: Safety, tolerability, and immunogenicity of a 20-valent pneumococcal conjugate vaccine in adults 60-64 years of age. <i>Oral presentation O0087 at the 29th European Congress of Clinical Microbiology &amp; Infectious Diseases.</i> Presented on Saturday 14 April 2019. <a target=xrefwindow id=d4550e2632 href="https://conferences.m3medical.com/eccmid-2019/article/promising-phase-ii-results-for-pneumococcal-vaccine/">Reference Source</a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734068435"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e2641 class=n-a></a>Greenberg D, Hoover PA, Vesikari T, <i> et al.</i>: Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants. <i>Vaccine.</i> 2018; <b>36</b>(45): 6883–91. <a target=xrefwindow id=d4550e2652 href="https://doi.org/10.1016/j.vaccine.2018.02.113">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734068435">F1000 Recommendation</a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734871118"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e2666 class=n-a></a>Stacey HL, Rosen J, Peterson JT, <i> et al.</i>: Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults. <i>Hum Vaccin Immunother.</i> 2019; <b>15</b>(3): 530–9. <a target=xrefwindow id=d4550e2677 href="http://www.ncbi.nlm.nih.gov/pubmed/30648919">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2680 href="https://doi.org/10.1080/21645515.2018.1532249">Publisher Full Text </a> | <a target=xrefwindow id=d4550e2684 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6605726">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734871118">F1000 Recommendation</a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734439301"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e2697 class=n-a></a>Peterson JT, Stacey HL, MacNair JE, <i> et al.</i>: Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. <i>Hum Vaccin Immunother.</i> 2019; <b>15</b>(3): 540–8. <a target=xrefwindow id=d4550e2708 href="http://www.ncbi.nlm.nih.gov/pubmed/30427749">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2711 href="https://doi.org/10.1080/21645515.2018.1532250">Publisher Full Text </a> | <a target=xrefwindow id=d4550e2715 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6605723">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734439301">F1000 Recommendation</a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d4550e2730 class=n-a></a>Lee C, Choi SK, Kim RK, <i> et al.</i>: Development of a new 15-valent pneumococcal conjugate vaccine (PCV15) and evaluation of its immunogenicity. <i>Biologicals.</i> 2019; <b>61</b>: 32–7. <a target=xrefwindow id=d4550e2741 href="http://www.ncbi.nlm.nih.gov/pubmed/31416790">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2744 href="https://doi.org/10.1016/j.biologicals.2019.07.005">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/737172164"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e2753 class=n-a></a>Converso TR, Assoni L, André GO, <i> et al.</i>: The long search for a serotype independent pneumococcal vaccine. <i>Expert Rev Vaccines.</i> 2020; <b>19</b>(1): 57–70. <a target=xrefwindow id=d4550e2764 href="http://www.ncbi.nlm.nih.gov/pubmed/31903805">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2767 href="https://doi.org/10.1080/14760584.2020.1711055">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/737172164">F1000 Recommendation</a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d4550e2781 class=n-a></a>Feldman C, Anderson R: Review: current and new generation pneumococcal vaccines. <i>J Infect.</i> 2014; <b>69</b>(4): 309–25. <a target=xrefwindow id=d4550e2789 href="http://www.ncbi.nlm.nih.gov/pubmed/24968238">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2792 href="https://doi.org/10.1016/j.jinf.2014.06.006">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/737155235"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e2801 class=n-a></a>Keech CA, Morrison R, Anderson P, <i> et al.</i>: A Phase 1 randomized, Placebo-controlled, observer-blinded trial to evaluate the safety and immunogenicity of inactivated <i>Streptococcus pneumoniae</i> whole-cell vaccine in adults. <i>Pediatr Infect Dis J.</i> 2020: <b>39</b>(4): 345–351. <a target=xrefwindow id=d4550e2815 href="http://www.ncbi.nlm.nih.gov/pubmed/31895881">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2819 href="https://doi.org/10.1097/INF.0000000000002567">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/737155235">F1000 Recommendation</a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/736779516"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e2833 class=n-a></a>Hammitt LL, Campbell JC, Borys D, <i> et al.</i>: Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: a phase IIb randomized study. <i>Vaccine.</i> 2019; <b>37</b>(51): 7482–92. <a target=xrefwindow id=d4550e2844 href="http://www.ncbi.nlm.nih.gov/pubmed/31629570">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2847 href="https://doi.org/10.1016/j.vaccine.2019.09.076">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/736779516">F1000 Recommendation</a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735539584"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4550e2861 class=n-a></a>Odutola A, Ota MOC, Antonio M, <i> et al.</i>: Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines - a phase II, randomised, observer-blind study in Gambian infants. <i>Vaccine.</i> 2019; <b>37</b>(19): 2586–99. <a target=xrefwindow id=d4550e2872 href="http://www.ncbi.nlm.nih.gov/pubmed/30975570">PubMed Abstract </a> | <a target=xrefwindow id=d4550e2875 href="https://doi.org/10.1016/j.vaccine.2019.03.033">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735539584">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 07 May 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-338/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-338/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, Johannesburg, 2193, South Africa<br/> <sup>2</sup> Institute of Cellular and Molecular Medicine, Department of Immunology, Faculty of Health Sciences, University of Pretoria, 5 Bophelo Road, Gezina, 0186, South Africa<br/> <p> <div class=margin-bottom> Charles Feldman <br/> <span>Roles: </span> Conceptualization, Data Curation, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Ronald Anderson <br/> <span>Roles: </span> Conceptualization, Data Curation, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/9-338/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 07 May 2020, 9:338 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.22341.1">https://doi.org/10.12688/f1000research.22341.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2020 Feldman C and Anderson R. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=24646 data-id=22341 data-downloads="" data-views="" data-scholar="10.12688/f1000research.22341.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/9-338/v1/pdf?article_uuid=60252632-e04b-4a09-a4b7-022abdcc1362" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.22341.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Feldman C and Anderson R. Recent advances in the epidemiology and prevention of <i>Streptococcus pneumoniae</i> infections [version 1; peer review: 2 approved] <i>F1000Research</i> 2020, <b>9</b>(F1000 Faculty Rev):338 (<a href="https://doi.org/10.12688/f1000research.22341.1" target=_blank>https://doi.org/10.12688/f1000research.22341.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=22341 id=mobile-track-article-signin-22341 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/22341?target=/articles/9-338/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=24646 /> <input name=articleId type=hidden value=22341 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Cheng-Hsun Chiu</strong>, Molecular Infectious Disease Research Center, Division of Pediatric Infectious Diseases, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taiwan </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Carlos Luna</strong>, Department of Medicine, Pulmonary Diseases Division, Hospital de Clínicas, Universidad de Buenos Aires, Argentina </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 07 May 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-338/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-338/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=67270-63157></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=67269-63156></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/9-338/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>07 May 20</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Cheng-Hsun Chiu</strong>, Molecular Infectious Disease Research Center, Division of Pediatric Infectious Diseases, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taiwan </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Carlos Luna</strong>, Department of Medicine, Pulmonary Diseases Division, Hospital de Clínicas, Universidad de Buenos Aires, Argentina </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/9-338/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/9-338/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in the epidemiology and prevention...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/9-338/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/9-338/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/9-338/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Feldman C and Anderson R');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/9-338/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/9-338",
            templates : {
                twitter : "Recent advances in the epidemiology and prevention of Streptococcus.... Feldman C and Anderson R, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/9-338/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in the epidemiology and prevention of Streptococcus pneumoniae infections", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in the epidemiology and prevention of Streptococcus pneumoniae infections", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/22341/24646")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "24646");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "63156": 2,
                           "63157": 1,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "6eda48d8-e59d-41c9-b81a-7c683ce7df67";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-338.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-338.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-338.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/9-338.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/9-338.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>